Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 31239 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–1233; Docket No. CDC–2022– 

0067] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Paul Coverdell 

National Acute Stroke Program 

(PCNASP) (DP21–2102) Evaluation. 

This project will collect information 

from funded PCNASP recipients to gain 

insight into the effectiveness of 

implementation approaches, including 

linking and using data, using teambased approaches to coordinate stroke 

care, and providing community 

resources in order to reach the general 

population and those at highest risk of 

stroke events, and reduce disparities in 

access to quality care for high burden 

populations. 

DATES: CDC must receive written 

comments on or before July 22, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0067 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Paul Coverdell National Acute Stroke 

Program (PCNASP) (DP21–2102) 

Evaluation (OMB Control No. 0920– 

1233)—Reinstatement—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The CDC is the primary federal 

agency for protecting health and 

promoting quality of life through the 

prevention and control of disease, 

injury, and disability. CDC is committed 

to programs that reduce the health and 

economic consequences of the leading 

causes of death and disability, thereby 

ensuring a long, productive, healthy life 

for all people. 

Stroke remains a leading cause of 

serious, long-term disability and is the 

fifth leading cause of death in the 

United States after heart disease, cancer, 

chronic lower respiratory diseases, and 

accidents. Estimates indicate that 

approximately 795,000 people suffer a 

first-ever or recurrent stroke each year 

with more than 146,000 deaths 

annually. Although there have been 

significant advances in preventing and 

treating stroke, the rising prevalence of 

heart disease, diabetes, and obesity has 

increased the relative risk for stroke, 

especially in African American 

populations. Moreover, stroke’s lifetime 

direct cost of health care and indirect 

cost of lost productivity is staggering 

and imposes a substantial societal 

economic burden. 

State programs funded through the 

Paul Coverdell National Acute Stroke 

Program (PCNASP) are in the forefront 

of developing and implementing 

system-change efforts to improve stroke 

systems of care by using strategies like 

linking and using data, using teambased approaches to coordinate stroke 

care, and providing community 

resources to reach the general 

populations and specifically those at 

highest risk of stroke events, and reduce 

disparities in access to quality care for 

high burden populations. 

When Congress directed the CDC to 

establish PCNASP in 2001, CDC 

intended to monitor trends in stroke and 

stroke care, with the ultimate mission of 

improving the quality of care for stroke 

patients in the United States. Since 

2021, CDC has funded and provided 

technical assistance to thirteen 

recipients to develop comprehensive 

stroke systems of care. A comprehensive 

system of care improves quality of care 

by creating seamless transitions for 

individuals experiencing stroke. In such 

a system, pre-hospital providers, inhospital providers, and early posthospital providers coordinate patient 

hand-offs and ensure continuity of care. 

While PCNASP has existed since 

2001, the goal and mission of the 

program has evolved with each funding 

cycle. The 2021–2024 funding cycle is 

the first such initiative to focus on 

addressing health equity specifically 

and understanding efforts to impact 

stroke outcomes for those at highest risk 

of stroke. CDC contracted with RTI 

International to conduct a national 

evaluation to assess program 


lotter on DSK11XQN23PROD with NOTICES1
31240 Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 

implementation as well as short term 

and intermediate outcomes of the 

thirteen funded recipients. 

CDC and RTI International propose to 

collect information from all thirteen 

funded PCNASP recipients to gain 

insight into the effectiveness of 

implementation approaches, including 

linking and using data, using team 

based approaches to coordinate stroke 

care, and providing community 

resources in order to reach the general 

population and those at highest risk of 

stroke events, and reduce disparities in 

access to quality care for high burden 

populations. 

The information collection will focus 

on describing PCNASP specific 

contributions to effective state-based 

stroke systems of care and the costs 

associated with this work. Two 

components of the information 

collection include: (1) Program 

implementation cost data collection 

from program recipients using a cost 

collection tool; and (2) interviews with 

key program and partner staff. Cost data 

collection will focus on recipients’ 

cumulative spending to support 

PCNASP activities, spending by 

reporting period, and spending 

associated with specific PCNASP 

strategies related to building 

comprehensive state-wide stroke 

systems of care and strategies focusing 

on high-risk populations. Interview 

questions will focus on how each 

recipient implemented its strategies to 

increase access to and quality of 

healthcare overall, as well as for 

patients at highest risk of stroke events. 

It will identify challenges encountered 

and how they were overcome, factors 

that facilitated implementation, lessons 

learned along the way, and observed 

outcomes and improvements. The 

information to be collected does not 

currently exist for large scale, statewide 

programs that employ multiple 

combinations of strategies to build 

comprehensive stroke systems of care. 

The insights to be gained from this 

data collection will be critical to 

improving immediate efforts and 

achieving the goals of spreading and 

replicating state-level strategies that are 

proven programmatically and are costeffective in contributing to a higher 

quality of care for stroke patients. OMB 

approval is requested for three years. 

CDC requests OMB approval for an 

estimated 104 annual burden hours. 

Participation is voluntary and there are 

no costs to respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Program Manager ............................. Cost Collection Tool ......................... 13 1 2 26 

Program Director ............................... Interview ........................................... 13 1 1 13 

Quality Improvement Specialist ........ Interview ........................................... 13 1 1 13 

Partner Support Staff ........................ Interview ........................................... 52 1 1 52 

Total ........................................... ........................................................... ........................ ........................ ........................ 104 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–10992 Filed 5–20–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control (BSC, NCIPC). This meeting 

is closed to the public. 

DATES: The meeting will be held on June 

8, 2022, from 1 p.m. to 4 p.m., EDT 

(CLOSED). 

ADDRESSES: Zoom Virtual Meeting. 

FOR FURTHER INFORMATION CONTACT: 

Arlene Greenspan, DrPH, MPH, PT, 

Associate Director for Science, NCIPC, 

CDC, 4770 Buford Highway NE, 

Mailstop S–1069, Atlanta, Georgia 

30341, Telephone: (770) 488–1279, 

Email: ncipcbsc@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

meeting designated above will be closed 

to the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, 

CDC, pursuant to Public Law 92–463 (5 

U.S.C. App. 2). 

Purpose: The Board will: (1) Conduct, 

encourage, cooperate with, and assist 

other appropriate public health 

authorities, scientific institutions, and 

scientists in the conduct of research, 

investigations, experiments, 

demonstrations, and studies relating to 

the causes, diagnosis, treatment, control, 

and prevention of physical and mental 

diseases, and other impairments; (2) 

assist States and their political 

subdivisions in preventing and 

suppressing communicable and noncommunicable diseases and other 

preventable conditions and in 

promoting health and well-being; and 

(3) conduct and assist in research and 

control activities related to injury. The 

Board of Scientific Counselors makes 

recommendations regarding policies, 

strategies, objectives, and priorities; and 

reviews progress toward injury 

prevention goals and provides evidence 

in injury prevention-related research 

and programs. The Board also provides 

advice on the appropriate balance of 

intramural and extramural research, as 

well as the structure, progress and 

performance of intramural programs. 

The Board is designed to provide 

guidance on extramural scientific 

program matters, including the: (1) 

Review of extramural research concepts 

for funding opportunity 

announcements; (2) conduct of 

Secondary Peer Review of extramural 

research grant, cooperative agreement, 

and contract applications received in 

response to funding opportunity 

announcements as they relate to the 

Center’s programmatic balance and 

mission; (3) submission of secondary 

review recommendations to the Center 

Director of applications to be considered 

for funding support; (4) review of 


lotter on DSK11XQN23PROD with NOTICES1